Post-acute sequelae of COVID-19: A disorder of impaired innate immune resolution – A narrative review
Clinical Immunology · 2026-06 · 285 · 110701
DOI: 10.1016/j.clim.2026.110701 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Immunology, 2026-06. Verfasst von Mahd Rauf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, University of the Punjab, Lahore 54590, Punjab, Pakistan. Hauptthemen laut MEDLINE: Immunity, Innate, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Post-acute sequelae of COVID-19 (PASC) affect millions of people worldwide and are increasingly recognized as a disorder of failed innate immune resolution rather than a persistent viral infection. Emerging evidence shows that residual SARS-CoV-2 antigens, host-derived alarmins, reactivated latent viruses, and mucosal microbiome-derived products from oral-nasopharyngeal and gut reservoirs sustain the chronic activation of pattern-recognition receptors, inflammasomes, and complement pathways. In parallel, deficits in specialized pro-resolving mediators, impaired efferocytosis, and persistent tissue injury prevent physiological termination of inflammation. These unresolved cues drive long-lasting epigenetic and metabolic reprogramming of hematopoietic stem cells and myeloid lineages, creating maladaptive trained immunity states characterized by hyper-responsiveness or exhaustion of these cells. Thromboinflammatory processes, including aberrant NETosis and sustained interface signalingling, further reinforce self-perpetuating inflammatory circuits. Together, these pathways give rise to reproducible molecular endotypes, including thromboinflammatory, interferon-driven, and neuroinflammatory phenotypes, which explain clinical heterogeneity. Framing PASC as a disorder of impaired immune resolution within a mucosal microbial viral context provides a unifying mechanistic scaffold for biomarker identification and host-directed therapies. This review proposes that restoring active resolution programs, rebalancing metabolic-epigenetic networks, and dismantling pathogenic innate feedback loops are promising strategies for reversing the chronic immune imprint of PASC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Molecular Genetics, University of the Punjab, Lahore 54590, Punjab, Pakistan.
- School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.
- Department of Biology, University of Ottawa, Ottawa, Ontario K1N 9A4, Canada. Electronic address: masghar@uottawa.ca.
Zitieren
APA
Rauf, M., Naveed, A., & Asghar, M. U. (2026). Post-acute sequelae of COVID-19: A disorder of impaired innate immune resolution – A narrative review. Clinical Immunology, 285, 110701. https://doi.org/10.1016/j.clim.2026.110701
Vancouver
Rauf M, Naveed A, Asghar MU. Post-acute sequelae of COVID-19: A disorder of impaired innate immune resolution – A narrative review. Clinical Immunology. 2026;285:110701. doi:10.1016/j.clim.2026.110701
BibTeX
@article{Rauf2026,
author = {Rauf, Mahd and Naveed, Ahsan and Asghar, Muhammad Umer},
title = {Post-acute sequelae of COVID-19: A disorder of impaired innate immune resolution – A narrative review},
journal = {Clinical Immunology},
year = {2026},
volume = {285},
pages = {110701},
doi = {10.1016/j.clim.2026.110701}
}
EUVIMED